ENZON PHARMACEUTICALS, INC. (OTC:ENZN) filed a Form 8-K with the Securities and Exchange Commission on February 11, 2026, disclosing a material event.
ENZON PHARMACEUTICALS, INC.'s stock currently trades at $0.06 with a market capitalization of $4.1M. The Healthcare company's stock moved following the disclosure.